Aquatic Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.06M | Sell |
176,704
-39,172
| -18% | -$678K | 0.06% | 355 |
|
|
2025
Q1 | $4.72M | Buy |
215,876
+86,667
| +67% | +$1.9M | 0.12% | 224 |
|
|
2024
Q4 | $4.12M | Buy |
129,209
+126,809
| +5,284% | +$4.05M | 0.11% | 236 |
|
|
2024
Q3 | $69.2K | Buy |
+2,400
| New | +$69.2K | ﹤0.01% | 959 |
|
|
2024
Q2 | – | Sell |
-2,300
| Closed | -$135K | – | 1205 |
|
|
2024
Q1 | $135K | Buy |
+2,300
| New | +$135K | ﹤0.01% | 852 |
|
|
2023
Q4 | – | Sell |
-29,800
| Closed | -$1.13M | – | 1309 |
|
|
2023
Q3 | $1.13M | Buy |
+29,800
| New | +$1.13M | 0.05% | 317 |
|